On a Friday in Leawood, Kansas, at the Parkinson’s Exercise and Wellness Center, classes are in full swing … literally. The ...

Botulinum neurotoxins (BoNT) have become a cornerstone in the treatment of hyperkinetic movement disorders, offering targeted and reversible ...

A team led by researchers at Chalmers University of Technology, Sweden, has succeeded in identifying biomarkers for Parkinson's disease in its earliest stages, before extensive brain damage has ...

Scientists in Sweden and Norway have uncovered a promising way to spot Parkinson’s disease years—possibly decades—before its most damaging symptoms appear. By detecting subtle biological signals in ...

New research reveals how Parkinson's spreads from the gut to the brain, with the help of immune cells – offering a new potential therapeutic strategy – in a study in mice led by scientists at the UK ...

Advanced Parkinson's disease patients in Calgary have had access since 2024 to a treatment called Vyalev, which an Edmonton ...

For more than 200 years, Parkinson’s disease has been treated as a one‑way street, with drugs and devices that ease symptoms ...

In a first, this week the U.S. Food and Drug Administration approved a brain stimulation device designed to treat depression at home. The approval of the first such device for home depression ...

Parkinson’s disease is a progressive movement disorder that damages nerve cells in the brain. This damage causes motor symptoms like tremor, stiffness, and problems with movement, and it can also ...

GSK’s potential “functional cure” for hepatitis B drug has proven its worth in a pair of hotly anticipated phase 3 studies, setting up the pharma for a push to the FDA. The British drugmaker had been ...